Adropin concentrations in term pregnancies with normal, restricted and increased fetal growth

References

• Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006;14:242S–9S
   PubMed Web of Science ®Google Scholar
• Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290–6
   PubMed Web of Science ®Google Scholar
• Muhlhausler BS, Duffield JA, Ozanne SE, et al. The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle. J Physiol (Lond) 2009;587:4199–211
   Google Scholar
• Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006;49:219–27
   PubMed Web of Science ®Google Scholar
• Krew MA, Kehl RJ, Thomas A, Catalano PM. Relation of amniotic fluid C-peptide levels to neonatal body composition. Obstet Gynecol 1994;84:96–100
   PubMed Web of Science ®Google Scholar
• Shanik MH, Xu Y, Skrha J, et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008;31:S262–8
   PubMed Web of Science ®Google Scholar
• Kumar KG, Trevaskis JL, Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 2008;8:468–81
   PubMed Web of Science ®Google Scholar
• Celik E, Yilmaz E, Celik O, et al. Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med 2013;41:375–80
   PubMed Web of Science ®Google Scholar
• Ganesh Kumar K, Zhang J, Gao S, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) 2012;20:1394–402
   PubMed Web of Science ®Google Scholar
• Lovren F, Pan Y, Quan A, et al. Adropin is a novel regulator of endothelial function. Circulation 2010;122:S185–92
   PubMed Web of Science ®Google Scholar
• Boutsikou T, Giotaki M, Gourgiotis D, et al. Cord blood netrin-1 and -4 concentrations in term pregnancies with normal, restricted and increased fetal growth. J Matern Fetal Neonatal Med 2014;27:1849–53
   PubMed Web of Science ®Google Scholar
• Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 1995;6:168–74
   PubMed Web of Science ®Google Scholar
• Kurmanavicious J, Florio I, Wisser J, et al. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol 1997;10:112–20
   PubMed Web of Science ®Google Scholar
• Chamberlain PF, Manning FA, Morrison I, et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol 1984;150:245–9
   PubMed Web of Science ®Google Scholar
• Burkhardt T, Schaffer L, Schneider C, et al. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol 2006;128:248–52
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 548: weight gain during pregnancy. Obstet Gynecol 2013;121:210–12
   PubMedGoogle Scholar
• Horvath TL. Synaptic plasticity in energy balance regulation. Obesity 2006;14:228S–33S
   PubMed Web of Science ®Google Scholar
• Begg DP, Woods SC. The central insulin system and energy balance. Handb Exp Pharmacol 2012;209:111–29
   PubMedGoogle Scholar
• Aydin S. Multi-functional peptide hormone NUCB2/nesfatin-1. Endocrine 2013;44:312–25
   PubMed Web of Science ®Google Scholar
• Gozal D, Kheirandish-Gozal L, Bhattacharjee R, et al. Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function. J Pediatr 2013;163:1122–6
   PubMed Web of Science ®Google Scholar
• Topuz M, Celik A, Aslantas T, et al. Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. J Investig Med 2013;61:1161–4
   PubMed Web of Science ®Google Scholar
• Qiu X, He JR, Zhao MG, et al. Relationship between human cord blood adropin levels and fetal growth. Peptides 2014;52:19–22
   PubMed Web of Science ®Google Scholar
• Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol 2004;28:67–80
   PubMed Web of Science ®Google Scholar
• Plagemann A, Harder T, Kohlhoff R, et al. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia 1997;40:1094–100
   PubMed Web of Science ®Google Scholar
• Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903–16
   PubMed Web of Science ®Google Scholar
• Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol 1999;17:119–25
   PubMedGoogle Scholar
• Butler AA, Tam CS, Stanhope KL, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab 2012;97:3783–91
   PubMed Web of Science ®Google Scholar
• Renom Espineira A, Fernandes-Rosa FL, Bueno AC, et al. Postnatal growth and cardiometabolic profile in young adults born large for gestational age. Clin Endocrinol (Oxf) 2011;75:335–41
   PubMed Web of Science ®Google Scholar
• Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19:2003–12
   PubMed Web of Science ®Google Scholar
• Koos RD. Minireview: putting physiology back into estrogens' mechanism of action. Endocrinology 2011;152:4481–8
   PubMed Web of Science ®Google Scholar